AzTrials
AzTrials

FallsFSSNCT03874728

The Effects of Minimal Shoes in Older People at Risk of Falls: The Feetback Shoe Study

An observational study of Falls and Aging, run by University of Liverpool at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A third of people over 65, and half of people over 80, fall at least once a year. Falls are the most common cause of death from injury in the over 65s and result in a significant financial burden on the whole society. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Falls, Aging
What is being tested?
Minimal shoes, Standardised conventional shoes and Barefoot
How many people
30 participants
Where
1 siteUnited Kingdom
Study dates
20 Nov 2019to 1 Mar 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Community-dwelling older adults

Who may be able to join

  • Age: ≥ 60 years old
  • One of the vulnerability criteria for risk falls:
  • ≥ 1 self-reported falls after the age of 60; (ii) balance impairment as indicated by a score <45 on the Berg Balance Scale, by a score >2 on the simplified Tinetti Gait \& Balance test or via any other validated and reliable clinical instrument used at the recruitment site; (iii) one or two criteria for physical frailty

Who cannot join

  • Macro-vascular symptoms (angina, stroke or a peripheral vascular disease)
  • Neuromuscular diseases (Multiple Sclerosis, Alzheimer Disease or Parkinson Disease)
  • Diabetes
  • Use of a walking aid (cane or walker)
  • Ankle, knee, hip surgery ≤ 3 months
  • Pain in the lower extremities of ≥ 8 on the numeric rating scale

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Liverpool

    Liverpool, Merseyside, L8 0TL

Other trials in United Kingdom

About this study

Official title: Preventing Falls in Older People Using an Innovative Connected Shoe: Development & Biomechanics Study.

A third of people over 65, and half of people over 80, fall at least once a year. Falls are the most common cause of death from injury in the over 65s and result in a significant financial burden on the whole society. Shoes directly influence balance, gait, and the subsequent risk of slips, trips and falls by altering somatosensory feedback to the foot and ankle. Minimal shoes, that is shoes lacking a firm heel cup, a rigid sole or longitudinal arch support, have shown advantages in strengthening muscles and improving balance as compared to conventional shoes. However, limited research has studied the effect of minimal shoe in older people at risk of falls. The aim of the project will be to assess the effects of minimal shoes in older people at risk of falls, compared to conventional shoes and barefoot.

Read the detailed description

Study participants will attend a one-day testing session at the Movement Laboratory, University of Liverpool. Participants will be subjected to several standing and walking tests while wearing three types of footwear in a randomised order: (i) a minimal shoe, (ii) a conventional shoe, and (iii) barefoot. Participants' physical function, stability during standing and walking and an activity of lower leg muscles will be assessed in each of those three footwear conditions. Participants will also be asked about perceptions of footwear, regarding a minimal shoe and a conventional shoe. At the end of assessments, participants will be asked to complete several walking bouts while wearing a minimal shoe with "smart" shoe insoles, to determine "smart" insoles' validity in obtaining gait characteristics against a gold standard measure. Finally, those participants who volunteer to take part in a two-week follow-up study, will be asked to wear the minimal shoes with "smart" insoles during daily life for two weeks, After two weeks, they will be asked to fill in an online questionnaire asking them about total time they used the minimal shoes and insoles and about how satisfied they were with them.

Conditions
Falls, Aging
Being tested
Minimal shoes, Standardised conventional shoes, Barefoot, "Smart" shoe insoles
Keywords
Falls, Gait, Stability, Muscle activity, Footwear, Minimal shoes, Smart shoe insoles

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Minimal shoesOther

    A minimal shoe (Vivobarefoot Ltd., London, UK) will be used.

  • Standardised conventional shoesOther

    The Go Walk 4.0-Pursuit shoe for women (Skechers USA, Inc.) and the Superior 2.0-Jeveno shoe for men (Skechers USA, Inc) will be used.

  • BarefootOther

    Participants will conduct the assessments barefoot.

  • "Smart" shoe insolesOther

    Arion pressure-measuring insoles (Eindhoven, The Netherlands) will be used in the study.

Study groups in NCT03874728
Study groupRoleWhat they receive
Older people at risk of fallsOlder people at risk of falls
Receives: Other: Minimal shoes; Other: Standardised conventional shoes; Other: Barefoot; Other: "Smart" shoe insoles

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timed Up and Go test

    Time (in seconds) to complete the Timed Up and Go test

    Measured: First day of joining the study

  2. Star Excursion Balance Test

    Reach (in centimetres) to achieve during the Star Excursion Balance Test

    Measured: First day of joining the study

  3. Postural stability

    Anterior-Posterior and latero-medial movement (in centimetres) of the centre of pressure

    Measured: First day of joining the study

  4. Dynamic stability

    Variability (standard deviations) of spatio-temporal gait characteristics

    Measured: First day of joining the study

  5. Muscle activity

    Electromyography activity for selected lower leg muscles and expressed in millivolts

    Measured: First day of joining the study

  6. Perceived attractiveness

    Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unattractive" and 100 mm being "extremely attractive"

    Measured: First day of joining the study

  7. Perceived attractiveness for others

    Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unattractive for others" and 100 mm being "extremely attractive for others"

    Measured: First day of joining the study

  8. Perceived comfort

    Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely uncomfortable" and 100 mm being "extremely comfortable"

    Measured: First day of joining the study

  9. Perceived weight

    Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely light" and 100 mm being "extremely heavy"

    Measured: First day of joining the study

  10. Perceived fit

    Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "poorest fit possible" and 100 mm being "best fit possible"

    Measured: First day of joining the study

  11. Perceived ease of use

    Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "most difficult as possible" and 100 mm being "as easy as imaginable"

    Measured: First day of joining the study

  12. Perceived stability

    Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unstable" and 100 mm being "extremely stable"

    Measured: First day of joining the study

Secondary outcomes (4)
  1. Validity of "smart" shoe insoles

    Validity of Arion insoles against Qualisys Motion Capture System

    Measured: First day of joining the study

  2. Adherence to wearing minimal shoes in daily life

    Adherence to wearing minimal shoes with "smart" shoe insoles assessed with an online questionnaire and expressed in total time in days and hours

    Measured: The assessment will be performed at 2 weeks

  3. Satisfaction of wearing minimal shoes in daily life

    Satisfaction of wearing minimal shoes with "smart" shoe insoles assessed with an online questionnaire and expressed on a 5-point Likert scale, with the following levels: 1 - Very dissatisfied, 2 - dissatisfied, 3 - unsure, 4 - satisfied, 5 - Very satisfied.

    Measured: The assessment will be performed at 2 weeks

  4. Gait characteristics during daily life

    Gait characteristics, assessed with "smart" shoe insoles, during activities of daily life and expressed in spatio-temporal metrics

    Measured: The assessment will be performed at 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Mar 2019
  2. Study start20 Nov 2019
  3. Primary completion1 Mar 2020
  4. Study completion1 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03874728
Sponsor's protocol ID
4151
Acronym
FSS
Status last verified
Jul 2020
First submitted
12 Mar 2019
Last updated
7 Jul 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Falls and Aging, run by University of Liverpool at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timed Up and Go test (time frame: First day of joining the study). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in